Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

The Calpain, Caspase 12, Caspase 3 Cascade Leading to Apoptosis Is Altered in F508del-CFTR Expressing Cells

Abstract

In cystic fibrosis (CF), the most frequent mutant variant of the cystic fibrosis transmembrane conductance regulator (CFTR), F508del-CFTR protein, is misfolded and retained in the endoplasmic reticulum (ER). We previously showed that the unfolded protein response (UPR) may be triggered in CF. Since prolonged UPR activation leads to apoptosis via the calcium-calpain-caspase-12-caspase-3 cascade and because apoptosis is altered in CF, our aim was to compare the ER stress-induced apoptosis pathway between wild type (Wt) and F508del-CFTR expressing cells. Here we show that the calcium-calpain-caspase-12-caspase-3 cascade is altered in F508del-CFTR expressing cells. We propose that this alteration is involved in the altered apoptosis triggering observed in CF.

Citation: Kerbiriou M, Teng L, Benz N, Trouvé P, Férec C (2009) The Calpain, Caspase 12, Caspase 3 Cascade Leading to Apoptosis Is Altered in F508del-CFTR Expressing Cells. PLoS ONE 4(12): e8436. https://doi.org/10.1371/journal.pone.0008436

Editor: Dominik Hartl, LMU University of Munich, Germany

Received: May 27, 2009; Accepted: December 2, 2009; Published: December 24, 2009

Copyright: © 2009 Kerbiriou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This work was supported by grants from the association Gaëtan Salaün, the “Etablissement Français du Sang” and the French CF foundation “Vaincre la Mucoviscidose”. Mathieu Kerbiriou was supported by the French foundation “Fondation pour la Recherche Médicale”. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Cystic fibrosis (CF) is the most common lethal autosomal recessive disease in the Caucasian population. It is due to mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene [1]–[3]. The most common mutation in CF is a missing phenylalanine at position 508 (F508del-CFTR) in the first nucleotide-binding domain of the CFTR protein. The misfolded F508del-CFTR protein does not traffic correctly to the plasma membrane and is degraded by proteasome [4]–[11]. Nevertheless, some F508del-CFTR is retained in the endoplasmic reticulum (ER) [12]. Beside the accumulation of F508del-CFTR in the ER, inflammation and infection are the major features of CF [13]. Eukaryotic cells respond to the accumulation of misfolded proteins in the ER, to inflammation and infection by activating the unfolded protein response (UPR) [14]–[15]. Some lines of evidence suggest that UPR is triggered in F508del-CFTR expressing cells due to the mutated protein itself or by exogenous factors [16]–[19]. UPR induces the transcription of genes encoding ER chaperones, protein-folding enzymes and components of the ER-associated degradation system, limiting new protein synthesis [20]–[24]. Whereas it is an adaptive process aimed to restore the ER homeostasis, it may lead to apoptosis due to an increased intracellular calcium ([Ca2+]i) content followed by the activation of the calpain (Cal-1 and -2), caspase (Csp) -12 and Csp-3 cascade [25]–[31].

Some studies have suggested perturbations in the apoptotic process in CF cell lines. Whereas it was shown that high DNA fragmentation, and likely apoptosis, is a feature of various epithelia in CF it is now admitted that failure to undergo apoptosis could contribute to the pathogenesis of the disease [32]–[35]. Therefore, according to UPR triggering in CF, our aim was to assess whether the [Ca2+]i, Cal-1, Cal-2, Csp-12 and Csp-3 cascade activation was modified in F508del-CFTR expressing cells when compared to wt-CFTR expressing cells. The comparison was also studied after UPR induction by thapsigargin (Tg). Using western blot experiment and Csp activity measurement, our results indicate that the cascade is altered in F508del-CFTR expressing cells. Indeed, we observed a decreased basal expression of Cal-1, Csp-12 and Csp-3 in delF508 expressing cells. Under stress conditions, the observed alterations were a lower expression of Cal-1, Cal-2, active form of Csp-12 and the absence of increased accumulation of the active form of Csp-3 in F508del-CFTR expressing cells. Furthermore, the Csp-12 and Csp-3 activities were decreased as well as the cells mortality. Therefore, we show that the altered apoptosis observed in CF under stress conditions (inflammation, infection) involves an altered Cal-1, Csp-12 and mostly Csp-3 activation.

Results

The first step of the studied cascade is a sustained increase in intracellular free [Ca2+] [27]. Therefore, we compared the basal free [Ca2+] between 16HBE14o- (wt-CFTR expressing cells) and CFBE41o- cells (F508del-CFTR expressing cells), using Fura-2 AM as a probe. No difference between 16HBE14o- and CFBE41o- cells regarding the basal [Ca2+]i was observed (Fig. 1). 16HBE14o- and CFBE41o- cells were further submitted to Tg treatment for 24, 30, 36 and 48 hours to induce ER stress. At the 24 hours time point the [Ca2+]i level was increased in both cell types indicating that the Tg treatment was efficient. The observed increased [Ca2+]i remained high until 48 hours. Nevertheless, the increased [Ca2+]i lower in CFBE41o- cells.

thumbnail
Download:
Figure 1. Comparison of the [Ca2+]i between 16HBE14o- and CFBE41o- cells.

16HBE14o- and CFBE41o- cells were loaded with Fura-2 AM and fluorescence was recorded at 340 nm (saturated calcium) and 380 nm (free calcium). The 340/380 nm ratio was calculated and compared between the two cell types at increasing times of Tg treatment. Whereas no significant difference was observed between the two cell types in the absence of Tg (0 time point), [Ca2+]i was increased in 16HBE14o- and CFBE41o- cells after 24 hours treatment. A significant lower [Ca2+]i was observed in the F508del-CFTR expressing cells. Bars represent SEM (n = 9).

https://doi.org/10.1371/journal.pone.0008436.g001

The Cal-1, Cal-2, Csp-12 and Csp-3 expressions without Tg treatment were compared using western blottings in 16HBE14o-, CFBE41o- and corrected CFBE41o- cells (CFBE41o- corr, Fig. 2A). The statistical analysis (Fig. 2B) showed that basal Cal-1, Csp-12 and Csp-3 expressions were decreased in CFBE41o- cells, whereas the Cal-2 expression was not modified. After 24, 30, 36 and 48 hours of ER stress due to Tg, Cal-1, Cal-2, Csp-12, Csp-3 expressions were assessed in the three cell types using western blottings (Fig. 3A). Cal-1 expression was increased in all the cell types after 24 hours treatment and remained higher than in the untreated cells until 48 hours (Fig. 3B). Nevertheless, the increased Cal-1 expression was lower in the F508del-CFTR expressing cells. After 48 hours treatment the Cal-1 expression was identical in 16HBE14o- and CFBE41o- cells, indicating that F508del-CFTR expressing cells needed a longer time to respond to Tg. No difference was observed between 16HBE14o- and CFBE41o-corr cells. After 24 hours of Tg treatment, Cal-2 expression was increased in all cell types but this increased expression remained lower in CFBE41o- cells (Fig. 3C). Therefore we concluded that F508del-CFTR cells exhibit an altered Cal-2 regulation when Tg is applied on the cells. The cleavage of Csp-12 in16HBE14o-, CFBE41o- and in CFBE41o-corr cells was studied using western blottings. The statistical analysis showed that the active form of Csp-12 was increased 24 hours after Tg treatment and reached a maximum after 30 hours in all cell types (Fig. 3D). The accumulation of the active form of Csp-12 was lower in F508del-CFTR expressing cells showing that the appearance of the cleaved form of Csp-12 is delayed when F508del-CFTR is expressed. In 16HBE14o- and in CFBE41o- corr cells the accumulation of the active form of Casp-3 was increased at 24 hours of treatment and progressively increased to reach a maximum after 36 hours of treatment (Fig. 3E). This pattern of expression was correlated to a decreased full length Csp-3 expression (not shown). In CFBE41o- cells, the Csp-3 expression was lower than in 16HBE14o- and CFBE41o- corr cells. In CFBE41o- cells, no accumulation of the active form of Csp-3 was observed before 48 hours of Tg treatment, indicating an important Csp-3 alteration (Fig. 3E). The full length Csp-3 expression was not modified in these cells at any time point (not shown). Therefore, under Tg treatment, Cal-1, Cal-2 and active Csp-12 accumulation were lower and delayed in CFBE41o- cells when compared to that of 16HBE14o- and CFBE41o- corr cells. The most significant result was a delayed and lower increased expression of the active form of Csp-3 in CFBE41o- cells after Tg stress.

thumbnail
Download:
Figure 2. Expression of Cal-1, Cal-2, Csp-12 and Csp-3 in 16HBE14o-, CFBE41o- corr and CFBE41o- cells.

A. Example of western blots showing the expression of Cal-1, Cal-2, pro-Csp-12, pro-Csp-3 and actin in 16HBE14o-, CFBE41o- corr and CFBE41o- cells. B. Histograms represent the quantification of Cal-1, Cal-2, pro-Csp-12 and pro-Csp-3 in 16HBE14o-, CFBE41o- corr and CFBE41o- cells The statistical analysis indicates a significant decreased of Cal-1, pro-Csp-12 and pro-Csp-3 in CFBE41o- cells. Bars represent SEM (n = 7).

https://doi.org/10.1371/journal.pone.0008436.g002

thumbnail
Download:
Figure 3. Expression of Cal-1, Cal-2, active Csp-12 and active Csp-3 in 16HBE14o-, CFBE41o- corr and CFBE41o- cells in the presence of Tg.

A. Example of western blots showing the expression of Cal-1, active Csp-12, active Csp-3 and actin in 16HBE14o- (1, 4, 7, 10, 13), in CFBE41o- corr cells (2, 5, 8, 11, 14) and CFBE41o- cells (3, 6, 9, 12, 15) at different time point of Tg treatment. B. Histogram represents the quantification of Cal-1 in 16HBE14o-, CFBE41o- corr and CFBE41o- cells in the absence (0 time point) and after 24, 30, 36 and 48 hours induction by Tg. In all cell types the Cal-1 is increased in the presence of Tg. The increased expression of Cal-1 is lower in CFBE41o- cells. At the 30 time point the difference is abolished. Bars represent SEM (n = 7). C. Histogram represents the quantification of Cal-2. In all cell types the Cal-2 is increased in the presence of Tg. The increased expression of Cal-1 is lower in CFBE41o- cells. Bars represent SEM (n = 7). D. Result of the statistical analysis of the active Csp-12 expression when Tg was applied on the cells. It indicates that the active Csp-12 is overexpressed in all cell types after Tg treatment. The overexpression is lower in F508del-CFTR expressing cells. Bars represent SEM (n = 7). E. The-quantification of the active Csp3 was performed using an ELISA kit as described in the methods. The histogram represents statistical analysis of the optical densities (OD, 450 nm) which are proportional to the quantity of the cleaved-Csp-3 in the cell lysates. It is observed that in 16HBE14o- and CFBE41o- corr cells the cleaved form is increased after 24 hours of Tg treatment whereas it is increased in CFBE41o- cells after 48 hours. Nevertheless, the amount of the cleaved-Csp-3 remains lower in CFBE41o- cells. Bars represent SEM (n = 6).

https://doi.org/10.1371/journal.pone.0008436.g003

Csp-12 and Csp-3 activities were measured by a fluorometric kit assay. For statistical analysis, the basal activities after 1 hour of Tg treatment (time point O) were chosen as 1 unit activity. Casp-12 basal activity was found to be decreased in CFBE41o- cells when compared to that of 16HBE14o- and CFBE41o- corr cells (Fig. 4A). Nevertheless, under Tg treatment the Csp-12 activity increased in all cell types. 36 hours after Tg treatment this activity was lower in F508del-CFTR expressing cells which exhibited a level corresponding to the non treated CFBE41o- and CFBE41o- corr cells. Therefore, this result suggested that F508del-CFTR expressing cells exhibit a decreased duration of Csp-12 activation when compared to CFTR expressing cells. Csp-3 activation was observed in 16HBE14o- and in CFBE41o- corr cells 24 hours after Tg treatment. The plateau phase observed after 24 hours was likely due to a sufficient amount of active Csp-3 to clive the whole substrate, showing that the maximal activity was reached. In CFBE41o- cells the basal Csp-3 activity was lower than in 16HBE14o- and CFBE41o- corr cells (Fig. 4B). Under Tg treatment despite increased [Ca2+]i, Cal-1, Cal-2 and Csp-12 levels and despite an increased Csp-12 activity, the Csp-3 activity was hardly detected and remained very low. This result was in accordance with accumulation of the active form of Csp-3 detected by ELISA.

thumbnail
Download:
Figure 4. Activities of Csp-12 and Csp-3 in 16HBE14o-, CFBE41o- corr and CFBE41o- cells in the presence of Tg.

Activities were measured by a fluorometric kit and the fluorescence after 1 hour incubation of 16HBE14o- cells with Tg was taken as reference. A. Histogram representing the results for the Csp-12 activity. The activity was increased in all cell types after 24 hours Tg. It was decreased in CFBE41o- cells at 48 hours. Bars represent SEM (n = 5). B. Histogram representing the results for the Csp-3 activity. It was increased in 16HBE14o- and CFBE41o- corr cells at the 24 hours time point and remained sustained until 48 hours. In CFBE41o- cells the Csp-3 activity was low and no increase among Tg incubation time was observed. Bars represent SEM (n = 6).

https://doi.org/10.1371/journal.pone.0008436.g004

Cal and Csp-12 activation are hallmarks of apoptosis [36]–[40]. We assessed the cell viability of 16HBE14o-, in CFBE41o- corr and CFBE41o- cells under Tg conditions. As shown in Fig. 5, the mortality was decreased in CFBE41o- cells independently of any treatment. After 36 hours of Tg treatment, the number of dead 16HBE14o- and CFBE41o- corr cells was increased and reached 80% (+/− 10%) at the 48 hours time point. Increased mortality was found in CFBE41o- cells. Nevertheless, the percentage of dead 16HBE14o- and CFBE41o- corr cells was higher than that of CFBE41o- cells (30% +/− 55%) at the 48 hours induction point. Therefore, a decreased cell death was observed in the F508del-CFTR expressing cells.

thumbnail
Download:
Figure 5. Percentage of mortality in 16HBE14o- and CFBE41o- cells in the presence of Tg.

The curves represent the mortality time course under Tg treatment. In both cell types it was increased with time. Nevertheless, the mortality was higher in 16HBE14o- and CFBE41o- corr cells after 36 hours of Tg treatment (p<0.001). Bars represent SEM (n = 5).

https://doi.org/10.1371/journal.pone.0008436.g005

Discussion

Mutations in the gene encoding CFTR are responsible for CF. The most common mutation F508del-CFTR, whose pathology is primarily due to a decrease in Cl permeability through the CFTR. The associated pathology is maintained by repeated lung infections, which provokes inflammatory responses that lead to lung fibrosis and respiratory failure in which lung necrosis is involved [41]. Furthermore, infected epithelial cells expressing mutant CFTR are less sensitive to apoptosis than cells expressing normal CFTR [35]. Because the released debris by cells undergoing necrosis initiate inflammatory response which is harmful in CF, it is important to understand why cells expressing mutant CFTR are more resistant to apoptosis than normal cells in the absence of infection. Consistent with this view, are the typical large DNA fragments of necrotic cells which are released by CF epithelia, increasing the viscosity of the mucus.

Beside the decreased Cl− permeability, the misfolded F508del-CFTR is partially retained in the ER where it activates UPR which can be enhanced by infection and inflammation [12], [14]–[19]. Indeed, UPR triggering due to the mutated CFTR expression was observed in A549 cells as well as in CFBE41o- cells which were used in the present study [17], [18]. It has been proposed that multiple UPR pathways contribute to ER stress-induced cell apoptosis, although the mechanisms still remain largely unknown. Nevertheless, the involvement of the [Ca2+]i, Cal-1 and -2, Csp -12 and Csp-3 cascade is suggested [25]–[31]. Therefore, our aim was to study this cascade in wt- and F508del-CFTR expressing cells and we showed that this pathway is altered when the mutated CFTR is expressed. Indeed, we observed decreased Cal-1 and Csp expressions in CF cells. Furthermore, we showed that under stress condition which was performed to mimic the exogenous stress observed in CF, Csp decreased expressions in CF cells were accompanied by a decreased activity, mostly regarding Csp-3 (Fig. 6). Interestingly, calpains deficiency was correlated with the resistance to ER stress-induced apoptosis which was directly related to a calpain requirement for the activation of Csp-12 and our results are consistent with previous studies showing that deficient cells for the pro-Csp-12 are resistant to ER stress-induced apoptosis [27], [28]. Nevertheless the present data regarding Csp-12 have to be moderated because its involvement in UPR in human is still controversial [42]–[44]. Indeed, previous data in humans and rodents indicate that the presence of Csp-12 attenuates responsiveness to bacterial invasion and confers a survival disadvantage [45].

thumbnail
Download:
Figure 6. Schematic presentation of molecular mechanisms involving calpains and caspases leading to apoptosis in F508del-CFTR expressing cells.

This schematic representation is adaptated from [27]. Black arrows indicate the pathway in CFTR expressing cells. In dark grey are our proposed modifications in F508del-CFTR expressing cells.

https://doi.org/10.1371/journal.pone.0008436.g006

In conclusion, we suggest that the [Ca2+]i, Cal-1 and -2, Csp -12 and Csp-3 cascade in involved in the CF physiopathology because this cascade is altered in CF cells and that the most important alteration concerns Csp-3. Therefore, the present results provide new fields of investigation regarding the altered apoptosis observed in CF.

Materials and Methods

Antibodies and Drugs

Monoclonal anti-Cal-1 (9A4H8D3, ab3589) and polyclonal anti-Cal-2 (2539) were purchased from abcam and Cell Signaling, respectively. Polyclonal anti-Csp-12 (2202) and monoclonal anti-Csp-3 (9662) were purchased from Cell Signaling. Secondary antibodies and the ECL+ detection kit were purchased from Amersham. Tg (T9033) and protease inhibitor cocktail (P8849) were from Sigma. Csp-12 Fluorometric Assay Kit (K139-100) and Csp-3 Fluorometric Assay Kit (K105-100) were from Biovision and were used to study the activity of these Csp.

Cell Culture and Treatment

Pr. D.C. Grüenert (San Francisco, CA, U.S.A) kindly provided the normal human bronchial polarized epithelial cells 16HBE14o- expressing the normal CFTR, their CF counterparts CFBE41o- expressing the F508del-CFTR and the corrected CFBE41o- cells [46]–[50]. The cells were cultured in Eagle's minimal essential medium (MEM) supplemented with 10% FBS and glutamine on an extracellular matrix (CellBind Corning, Bioblock). To induce ER calcium depletion and the activation of the [Ca2+]i, Cal-1, Cal-2, Csp-12 and Csp-3 cascade, cells were treated with 5 µM Tg for 24, 30, 36 and 48 hours.

Viability Assays

Cell viability after Tg treatment was determined by trypan blue exclusion. Cells were trypsinized, resuspended in phosphate buffer saline (PBS), incubated with 0.4% trypan blue (prepared in PBS) for 8 min and counted (at least 600) for calculation of percentage of residual cell viability, as previously described [26].

Fura 2-AM Measurement

[Ca2+]i in 16HBE14o- and CFBE41o- cells with and without Tg treatment was measured using the Ca2+-sensitive fluorescent probe fura-2 acetoxy-methyl ester (Fura-2 AM, Invitrogen). Cells were loaded for 45 min in the dark with 2.5 µM Fura-2 AM at 37°C. They were rinsed twice and incubated in Tyrode solution for 20 min at 37°C. Fluorescence was recorded using the fluorescence microscope (IX-71, Olympus, France) at 340 nm (saturated Ca2+) and 380 nm (free Ca2+) and was further analyzed using Fluostar software (IMSTAR, France). For each experiment, 20–30 cells were observed, the responses were compared to the controls obtained with untreated cells and the [Ca2+]i concentration was calculated as previously described [51].

Protein Extraction and Western Blotting

Cell lysates were prepared from 16HBE14o- and CFBE41o- cells in lysis buffer (50 mM Tris HCl, 100 mM NaCl, 1% Triton X-100) in the presence of protease inhibitor cocktail (5 µL/mL; 1.1 µM leupeptin, 0.7 µM aprotinin, 120 µM PMSF, 1 µM iodoacetamide, 0.7 µM pepstatin and 1 mM DIFP). Protein concentrations were determined by the method of Lowry et al. using bovine serum albumine as a standard [50]. Equal amounts of total proteins for each sample were submitted to 37°c heating and subjected to SDS/PAGE (12%). After blotting, the membranes were saturated in PBS containing 0.2% fat free milk, incubated overnight (4°c) with anti-Cal-1 (1/1000), anti-Cal-2 (1/1000), anti-Csp-12 (1/500) and anti-Csp-3 (1/500) antibodies and with appropriate secondary antibodies (1/5000). Revelations were performed using an ECL+ detection kit. Densitometric analysis of the signals was performed using a GelDoc 2000 apparatus (Biorad) and each value was normalized by the total amount of loaded proteins per lane which was estimated after coomassie blue staining of the membrane and by the actin signal obtained on the same membranes, which did not vary among cell types.

Cleaved Csp-3 Detection

A solid phase sandwich enzyme-linked immunosorbent assay (ELISA, Cell Signaling) was used to detect and quantify the cleaved Csp-3, according to the manufacturer's instructions. In this assay, a total Csp-3 antibody is coated onto microwells. After incubation with the cell lysates, cleaved and uncleaved Csp-3 is captured. Following extensive washing a biotinylated cleaved-Csp-3 antibody is used to specifically detect this form of the protein. The magnitude of optical density (OD, 450 nm) of the coloured reaction is proportional to the quantity of cleaved-Csp-3 (17 kDa). All time points were performed in triplicate and the experiment was performed three times.

Caspases Activities Assays

Csp-12 and Csp-3 activities were measured by a fluorometric kit assay according to manufacturer's instructions. In brief, cells were lysed and the proteins (20 µg) were incubated with the Csp-12 substrate ATAD-AFC (50 µg) or with the Csp-3 substrate DEVAD-AFC (50 µg), for 2 hours at 37°C. Samples are transferred in black bottom 96 wells microplates and were read in a fluorescence microplate reader (Fluoroskan Ascent; Labsystems). The non-clived substrate emission was 400 nm (blue) and the clived substrate emission was 505 nm (green). The control reactions were performed with no protein in the wells and by omitting the substrate. Experiments were performed in triplicate.

Statistical Analysis

Data are shown as mean ± standard error of mean (SEM). Differences between experimental groups were evaluated by a two-tailed unpaired Student's t test. p<0.05 was considered significant (*), p<0.001 was considered very significant (**) and p<0.0001 was considered highly significant.

Acknowledgments

The authors thank the association Gaëtan Salaün, the “Etablissement Français du Sang”, the French CF foundation “Vaincre la Mucoviscidose” and the French foundation “Fondation pour la Recherche Médicale”.

Author Contributions

Conceived and designed the experiments: PT CF. Performed the experiments: MK LT NB. Analyzed the data: PT. Contributed reagents/materials/analysis tools: MK. Wrote the paper: PT.

References

  1. 1. Kerem BS, Rommens JM, Buchana JA, Markiewicz D, Cox TK, et al. (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073–1080.
  2. 2. Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, et al. (1989) Identification of the cystic fibrosis gene: clonic and characterization of complementary DNA. Science 245: 1066–1073.
  3. 3. Rommens JM, Lannuzzi MC, Kerem BS, Drumm ML, Melmer G, et al. (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059–1065.
  4. 4. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, et al. (1990) Defective intracellular transport and processing of CFTR is the molecular basis for most of cystic fibrosis. Cell 63: 827–834.
  5. 5. Denning GM, Ostedgaard LS, Welsh MJ (1992) Abnormal localization of Cystic Fibrosis Transmembrane Conductance Regulator in primary cultures of cystic fibrosis airway epithelia. J Cell Biol 118: 551–559.
  6. 6. Kartner N, Augustinas O, Jensen TJ, Naismith AL, Riordan JR (1992) Mislocalization of ΔF508 CFTR in cystic fibrosis sweat glands. Nat Genet 1: 321–327.
  7. 7. Lukacs GL, Mohamed A, Kartner N, Chang XB, Riordan JR, et al. (1994) Conformational maturation of CFTR but not its mutant counterpart (Delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J 13: 6076–6086.
  8. 8. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, et al. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358: 761–764.
  9. 9. Kopito RR (1999) Biosynthesis and degradation of CFTR. Physiol Rev 79: S167–S173.
  10. 10. Du K, Sharma M, Lukacs GL (2005) The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat Struct Mol Biol 12: 17–25.
  11. 11. Younger JM, Ren HY, Chen L, Fan CY, Fields A, et al. (2004) A foldable CFTR (Delta) F508 biogenic intermediate accumulates upon inhibition of the Hsc70-CHIP E3 ubiquitin ligase. J Cell Biol 167(6): 1075–85.
  12. 12. Gilbert A, Jadot M, Leontieva E, Wattiaux-De Coninck S, Wattiaux R (1998) ΔF508 CFTR localizes in the endoplasmic reticulum-Golgi intermediate compartment in cystic fibrosis cells. Exp Cell Res 242: 144–152.
  13. 13. Heijerman H (2005) Infection and inflammation in cystic fibrosis: a short review. J Cyst Fibros 4: Suppl 23–5.
  14. 14. Gu J, Rihl M, Marker-Hermann E, Baeten D, Kuipers JG, et al. (2004) Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J Gastroenterol 10: 1699–708.
  15. 15. Zhang K, Shen X, Wu J, Sakaki K, Saunders T, et al. (2006) Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 124: 587–599.
  16. 16. Bartoszewski R, Rab A, Jurkuvenaite A, Mazur M, Wakefield J, et al. (2008) Activation of the Unfolded Protein Response by {Delta}F508 CFTR. Am J Respir Cell Mol Biol 39(4): 448–457.
  17. 17. Bartoszewski R, Rab A, Twitty G, Stevenson L, Fortenberry J, et al. (2008) The mechanism of cystic fibrosis transmembrane conductance regulator transcriptional repression during the unfolded protein response. J Biol Chem 283(18): 12154–65.
  18. 18. Kerbiriou M, Le Drévo MA, Férec C, Trouvé P (2007) Coupling cystic fibrosis to endoplasmic reticulum stress: Differential role of Grp78 and ATF6. Biochim Biophys Acta 1772(11–12): 1236–49.
  19. 19. Rab A, Bartoszewski R, Jurkuvenaite A, Wakefield J, Collawn JF, et al. (2007) Endoplasmic reticulum stress and the unfolded protein response regulate genomic cystic fibrosis transmembrane conductance regulator expression. Am J Physiol Cell Physiol 292(2): C756–66.
  20. 20. Pilewski JM, Frizzell RA (1999) Role of CFTR in airway disease. Physiol Rev 79: S215–S255.
  21. 21. Kaufman RJ, Scheuner D, Schroder M, Shen X, Lee K, et al. (2002) The unfolded protein response in nutrient sensing and differenciation. Nat Rev Mol Cell Biol 3: 411–421.
  22. 22. Patil C, Walter P (2001) Intracellular signalling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr Opin Cell. Biol 13: 349–355.
  23. 23. Ron D (2002) Translational control in the endoplasmic reticulum stress response. J Clin Investig 110: 1383–1388.
  24. 24. Travers KJ, Patil CK, Wodicka L, Lockhart DJ, Weissman JS, et al. (2000) Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101: 249–258.
  25. 25. Xu C, Bailly-Maitre B, Reed JC (2005) Endoplasmic reticulum stress: cell life and death decisions. Journal of Clinical Investigation 115: 2656–64.
  26. 26. Das A, Banik NL, Ray SK (2006) Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids. International Journal of Cancer 2575–2585.
  27. 27. Nakagawa T, Zhu H, Morishima E, Li E, Xu J, et al. (2000) Caspase 12 mediates endoplasmic reticulum specific apoptosis and cytotoxicity by amyloid-beta. Nature 403: 98–103.
  28. 28. Nakagawa T, Yuan J (2000) Cross-talk between two cysteine protease families: Activation of Caspase-12 by Calpain in apoptosis. J Cell Biol 150: 887–894.
  29. 29. Sergeev IN (2004) Calcium as a mediator of 1,25-dihydroxyvitamin D3-induced apoptosis. The Journal of Steroid Biochemistry and Molecular Biology 89: 419–425.
  30. 30. Bajaja G, Sharma RK (2006) TNF-α-mediated cardiomyocyte apoptosis involves caspase-12 and calpain. BBRC 345: 1558–64.
  31. 31. Tan Y, Dourdin N, Wu C, De Veyra T, Elce JS, et al. (2006) Ubiquitous Calpains Promote Caspase-12 and JNK Activation during Endoplasmic Reticulum Stress-induced Apoptosis. J Biol Chem. 281: 16016–24.
  32. 32. Maiuri L, Raia V, De Marco G, Coletta S, De Ritis G, et al. (1997) DNA fragmentation is a feature of cystic fibrosis epithelial cells: a disease with inappropriate apoptosis? FEBS Lett 408(2): 225–31.
  33. 33. Gottlieb R, Dosanjh A (1996) Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells: Possible relevance to cystic fibrosis. Proc Natl Acad Sci USA 93: 3587–91.
  34. 34. Jungas T, Motta I, Duffieux F, Fanen P, Stoven V, et al. (2002) Glutathione levels and BAX activation during apoptosis due to oxidative stress in cells expressing wild-type and mutant cystic fibrosis transmembrane conductance regulator J Biol Chem 277: 27912–18.
  35. 35. Cannon CL, Kowalski MP, Stopak KS, Pier GB (2003) Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. Am J Respir Cell Mol Biol 29(2): 188–197.
  36. 36. Nakagawa T, Yuan J (2000) Cross-talk between Two Cysteine Protease Families: Activation of Caspase-12 by Calpain in Apoptosis. J Cell Biol 150: 887–94.
  37. 37. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, et al. (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403: 98–103.
  38. 38. Yoneda T, Imaizumi K, Oono K, Yui D, Gomi F, et al. (2001) Activation of Caspase-12, an Endoplastic Reticulum Resident Caspase through Tumor Necrosis Factor Receptor-associated Factor 2-dependent Mechanism in Response to the ER Stress. J Biol Chem 276: 13935–13940.
  39. 39. Rao RV, Hermel E, Castro-Obregon S, Del Rio Guerra G, Ellerby LM, et al. (2001) Coupling Endoplasmic Reticulum Stress to the Cell Death Program. J Biol Chem 276: 33869–33874.
  40. 40. Rao RV, Peel A, Logvinova A, Del Rio Guerra G, Hermel E, et al. (2002) Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 514: 122–128.
  41. 41. Konstan MW, Berger M (1997) Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 24: 137–161.
  42. 42. Lien YC, Kung HN, Lu KS, Jeng CJ, Chau YP (2008) Involvement of endoplasmic reticulum stress and activation of MAP kinases in beta-lapachone-induced human prostate cancer cell apoptosis. Histol Histopathol 23(11): 1299–1308.
  43. 43. Shellman YG, Howe WR, Miller LA, Goldstein NB, Pacheco TR, et al. (2008) Hyperthermia induces endoplasmic reticulum-mediated apoptosis in melanoma and non-melanoma skin cancer cells. J Invest Dermatol 128(4): 949–956.
  44. 44. Roy S, Sharom JR, Houde C, Loisel TP, Vaillancourt JP, et al. (2008) Confinement of caspase-12 proteolytic activity to autoprocessing. Proc Natl Acad Sci U S A 105(11): 4133–4138.
  45. 45. Fischer H, Koenig U, Eckhart L, Tschachler E (2002) Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun 293: 722–726.
  46. 46. Cozens AL, Yessi MJ, Kunzelmann K, Ohrui T, Chin L, et al. (1994) CFTR expression and Chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 10: 38–47.
  47. 47. Bruscia E, Sangiuolo F, Goncz KK, Novelli G, Gruenert DC (2002) Isolation of CF cell lines corrected at ΔF508-CFTR locus by SFHR-mediated targeting. Gene Therapy 9: 683–685.
  48. 48. Le Drévo MA, Benz N, Kerbiriou M, Giroux-Metges MA, Pennec JP, et al. (2008) Annexin A5 increases the cell surface expression and the chloride channel function of the ΔF508-Cystic Fibrosis Transmembrane Regulator. Biochimica et Biophysica Acta 1782: 605–614.
  49. 49. Illek B, Maurisse R, Wahler L, Kunzelmann K, Fischer H, et al. (2008) Cl transport in complemented CF bronchial epithelial cells correlates with CFTR mRNA expression levels. Cell Physiol Biochem 22(1–4): 57–68.
  50. 50. Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260(6): 3440–50.
  51. 51. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1): 265–275.